ion, National Institute for Occupational Safety and Health, DHHS (NIOSH) Publication No. 2004-165.
OSHA Technical Manual, TED 1-0.15A, Section VI: Chapter 2. Controlling occupational exposure to hazardous drugs. OSHA, 1999. http://www.osha.gov/dts/osta/otm/otm_vi/otm_vi_2.html
American Society of Health-System Pharmacists. ASHP guidelines on handling hazardous drugs. Am J Health-Syst Pharm. 2006;63:1172-1193.
Polovich M, White JM, Kelleher LO, eds. 2005. Chemotherapy and biotherapy guidelines and recommendations for practice. 2nd ed. Pittsburgh, PA: Oncology Nursing Society.
Manufactured by:
Nippon Kayaku Co., Ltd.
Tokyo, Japan
Distributed by:
Bristol-Myers Squibb Company
Princeton, NJ 08543 USA
Rev April 2010
-----------------------------------------
REPRESENTATIVE PACKAGING
See How Supplied section for a complete list of available packages of BLENOXANE.
NDC 0015-3010-20
BLENOXANE®
(bleomycin sulfate for injection, USP)
EQUIVALENT TO
15 units bleomycin
Rx only
BLENOXANE
bleomycin sulfate injection, powder, for solution
Product Information
Product Type HUMAN PRESCRIPTION DRUG NDC Product Code (Source) 0015-3010
Route of Administration INTRAVENOUS, INTRAMUSCULAR, SUBCUTANEOUS, INTRAPLEURAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
bleomycin sulfate (bleomycin) bleomycin sulfate 15 [USP'U]
Inactive Ingredients
Ingredient Name Strength
No Inactive Ingredients Found
Product Characteristics
Color Score
Shape Size
Flavor Imprint Code
Contains
Packaging
# NDC Package Description Multilevel Packaging
1 0015-3010-20 10 VIAL In 1 CARTON contains a VIAL
1 1 VIAL In 1 VIAL This package is contained within the CARTON (0015-3010-20)
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NDA NDA050443 06/01/2009 01/31/2010
BLENOXANE
bleomycin sulfate injection, powder, for solution
Product Information
Product Type HUMAN PRESCRIPTION DRUG NDC Product Code (Source) 0015-3063
Route of Administration INTRAVENOUS, INTRAMUSCULAR, SUBCUTANEOUS, INTRAPLEURAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
bleomycin sulfate (bleomycin) bleomycin sulfate 30 [USP'U]
Inactive Ingredients
Ingredient Name Strength
No Inactive Ingredients Found
Product Characteristics
Color Score
Shape Size
Flavor Imprint Code
Contains
Packaging
# NDC Package Description Multilevel Packaging
1 0015-3063-01 1 VIAL In 1 CARTON contains a VIAL
1 1 VIAL In 1 VIAL This package is contained within the CARTON (0015-3063-01)
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NDA NDA050443 06/01/2009 02/28/2010
Labeler - E.R. Squibb & Sons, L.L.C. (006370092)
Revised: 05/2010E.R. Squibb & Sons, L.L.C. |
